Request for Covid-19 Impact Assessment of this Report
These infections are generally caused by pathogens which spread very quickly in the body. Also, due to the patients already effected immune system and vulnerable conditions in a hospital, the infections spread at a greater rate than the normal infections. These infections are treated by prescription of antibiotics, consumption of a proper & healthy diet, and by encouraging natural healing process. The infection can be prevented by keeping the hospital facility premises and surroundings hygienic. The most prevelant type of hospital acquired infections is a urinary tract infection.
Market Dynamics
Poor infection control methods and lack of proper training among staff have resulted in increased risk of HAIs in hospitals and similar places. This rising prevalence of HAIs which has resulted in increased awareness about HAIs, government programs for awareness about HAIs and promoting policies for increased anti-HAI procedures and technology coupled with increasing number of operations around globe and large-scale use of disinfectors are creating new and greater market opportunities for HAI Control.
However, infrastructural constrains like dearth of supplies, proper buildings, medical and communication equipment along with strict regulatory policies, lack of awareness and untrained and naïve staff hamper the growth of global market for HAI Control.
Market Segmentation
The Hospital acquired infection control market is segmented on the basis of infection prevention, end user,infection testing, and region. The market is further bifurcated into various segments all of which have different contribution in the global market. This is discussed below:
On the basis of Infection Prevention
o Endoscope Reprocessors
o Sterilizers
o Disinfectors
o Disinfectants
-> Type
--> Instrument Disinfectants
--> Hand Disinfectants
--> Surface Disinfectants/ Disinfectant Robots
--> Skin Disinfectants
-> By Formulation
--> Disinfectant Sprays
--> Disinfectant Wipes
--> Disinfectant Liquids
Due to the extensive use of disinfectants across the healthcare industry they account for the largest share in the market among these segments.
--> On the basis of end user
o Hospitals and Intensive Care Units (ICUs)
o Nursing Homes and Maternity Centres
o Ambulatory Surgical and Diagnostic Centres
o Others
Among these Hospitals and ICUs accounted for the largest share owing to the prevalence of a large number of HAIs in these areas.
--> On the basis of Infection testing
o Application
-> Drug Resistance Testing
-> Disease Testing
o Product
-> Microbial Testing Instruments
--> Automated Microbial Identification Systems
--> Microarrays
--> Polymerase Chain Reaction (PCR) Instruments
--> Flow Cytometers
--> Mass Spectrometers
--> Polystainers
--> Others
-> Reagents and Consumables
-> Surveillance Software
-> Infection Prevalence
o Disease
-> Hospital Acquired Pneumonia
-> Gastrointestinal Infections
-> Surgical Site Infections
-> Bloodstream Infections
-> Urinary Tract Infections (UTI)
-> Others
o Technology
-> Phenotypic Methods
--> Phage-Based Assays
--> Nitrate Reductase Assay
--> Colorimetric Methods
-> Genotypic Methods
--> Solid-Phase Hybridization Techniques
--> Polymerase Chain Reaction Techniques
--> DNA Sequencing
--> Microarrays
--> On the basis of region
o North America
o Europe
o Asia Pacific
-> China
-> India
o Rest of the world
Geographic Analysis
Geographically the market is segmented into three different regions:north America, Europe, Asia Pacific and China(APAC) and rest of the world. Among these North America dominates the market in the global world. This is due to the technological advancements in the region coupled with increasing demand for better healthcare facilities and awareness among the masses regarding Hospital Acquired Infections(HAIs). The USA is the largest contributor in the north American region for HAI Control market.
However, Asia Pacific is expected to show the highest growth in the global market in the next five years. This is due to the increasing geriatrics population which in turn results in a higher number of chronic diseases. Also, increasing demand for better healthcare facilities, rising number of medical tourism in developing countries like India and China, rising number of hospitals, greater number of HAIs are also the contributing factors for this future increase in global market share.
Key Players
The key players who are driving the market of Hospital acquired infection control and determine its future are: Becton, Dickinson and Company (U.S.), Advanced Sterilization Products (U.S., a division of Ethicon US, LLC), Kimberly-Clark Corporation (U.S.), BioMérieux SA (France), Belimed AG (Switzerland), Cantel Medical (U.S.), Sterigenics International LLC. (U.S.), and Synergy Health, plc (U.K.), Getinge Group (Sweden), STERIS Corporation(USA), Sterilization Products Division, 3M company (U.S.)Hoffmann-La Roche Ltd,and Pfizer Inc.
The report contains comprehensive analysis on:
--> Hospital acquired infection control market segments
--> Hospital acquired infection control market drivers, restraints and opportunities
--> Hospital acquired infection control market size and forecast 2016 to 2022
--> Supply and demand value chain
--> Hospital acquired infection control market current trends
--> Competition and major companies
--> Technology and R&D status
--> Porters five force analysis
--> Strategic and critical success factor analysis of key players
The regional analysis of Hospital acquired infection control market includes:
--> North America
>> US and Canada
--> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
--> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
--> Eastern Europe
>> Russia
>> Poland
>> Rest of Eastern Europe
--> Asia Pacific
>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific
--> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides in-depth market segmentation that is derived from extensive product mapping exercises, macro-economic factors and other qualitative and quantitative insights. The impact of all such factors are delivered across multiple market segments and geographies.
Report Highlights::
--> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
--> Consumer and Pricing Analysis
--> Market dynamics of the industry
--> In-depth Market Segmentation
--> Historical and Projected Market Sizing in terms of volume and value
--> Recent market trends and Impact Factors
--> R&D Status and Technology Overview
--> Extensive Industry Structure Coverage
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...